| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 88.48B | 98.68B | 84.19B | 73.69B | 61.03B | 56.91B |
| Gross Profit | 19.41B | 24.62B | 17.14B | 12.44B | 9.31B | 8.84B |
| EBITDA | 11.71B | 16.35B | 10.04B | 6.16B | 3.52B | 3.38B |
| Net Income | 8.34B | 11.80B | 7.26B | 4.51B | 2.34B | 2.24B |
Balance Sheet | ||||||
| Total Assets | 78.42B | 100.87B | 80.16B | 76.23B | 63.46B | 63.70B |
| Cash, Cash Equivalents and Short-Term Investments | 18.01B | 19.82B | 12.77B | 10.02B | 13.26B | 14.87B |
| Total Debt | 810.00M | 105.00M | 65.00M | 125.00M | 65.00M | 165.00M |
| Total Liabilities | 24.89B | 34.51B | 27.21B | 27.04B | 20.08B | 21.23B |
| Stockholders Equity | 53.53B | 66.31B | 52.95B | 49.19B | 43.38B | 42.46B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 11.69B | 4.45B | -1.60B | -308.00M | 659.00M |
| Operating Cash Flow | 0.00 | 12.15B | 4.65B | -1.45B | -157.00M | 904.00M |
| Investing Cash Flow | 0.00 | -940.00M | -159.00M | -340.00M | -625.00M | -130.00M |
| Financing Cash Flow | 0.00 | -4.25B | -1.79B | -1.72B | -883.00M | -565.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥118.66B | 10.28 | ― | 1.55% | 17.21% | 65.71% | |
78 Outperform | ¥265.91B | 14.08 | 7.43% | 2.78% | 2.69% | -6.90% | |
78 Outperform | ¥618.48B | 15.42 | ― | 2.15% | 0.46% | 38.67% | |
75 Outperform | ¥157.79B | 12.39 | ― | 2.81% | 12.49% | 26.21% | |
73 Outperform | ¥71.78B | 18.40 | ― | 2.95% | 22.68% | 48.79% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | ¥64.11B | 11.91 | ― | 2.73% | -2.86% | 50.42% |